BIVI Logo

BioVie Inc. (BIVI) 

NASDAQ$1.12
Market Cap
$20.67M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
486 of 922
Rank in Industry
285 of 526

BIVI Insider Trading Activity

BIVI Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$00–
Sells
$00–

Related Transactions

No records found

About BioVie Inc.

BioVie Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of drugs therapies in the United States. Its products in pipeline include BIV201, which completed Phase IIa clinical trial for the treatment of ascites due to chronic liver cirrhosis; and NE3107, which is in Phase III clinical trial for the treatment of patients with mild to moderate Alzheimer's disease and Phase I clinical trial for the treatment of Parkinson's disease. The company is also developing NE3107, which is in â€¦

Insider Activity of BioVie Inc.

Over the last 12 months, insiders at BioVie Inc. have bought $0 and sold $0 worth of BioVie Inc. stock.

On average, over the past 5 years, insiders at BioVie Inc. have bought $158,007 and sold $352,703 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 10,000 shares for transaction amount of $10,000 was made by DO CUONG V (President & CEO) on 2024‑03‑04.

List of Insider Buy and Sell Transactions, BioVie Inc.

2024-03-04PurchaseDO CUONG VPresident & CEO
10,000
0.0236%
$1.00$10,000-71.31%
2023-12-01SaleGORLIN STEVEdirector
75,680
0.2029%
$1.69$127,899-72.14%
2023-11-30PurchaseDO CUONG VPresident & CEO
10,000
0.0263%
$1.78$17,800-73.89%
2023-09-05SaleGORLIN STEVEdirector
8,560
0.023%
$3.05$26,108-74.26%
2023-08-22SaleBERMAN RICHARD Jdirector
10,805
0.0289%
$3.50$37,827-70.51%
2023-06-07SaleBERMAN RICHARD Jdirector
5,984
0.017%
$5.81$34,782-69.90%
2023-05-22SaleBERMAN RICHARD Jdirector
5,000
0.0137%
$6.50$32,506-54.90%
2023-03-28SaleBERMAN RICHARD Jdirector
7,613
0.0213%
$8.52$64,870-59.33%
2023-03-27SaleBERMAN RICHARD Jdirector
3,371
0.0096%
$8.52$28,711-58.32%
2021-12-07PurchaseKIM JOANNE WENDYCFO
2,000
0.0084%
$5.40$10,798-38.99%
2020-11-03PurchaseGORLIN STEVEdirector
2,430
0.0171%
$7.95$19,319+78.22%
2020-10-30PurchaseGORLIN STEVEdirector
2,570
0.0185%
$7.97$20,483+81.68%
2020-10-21PurchaseGORLIN STEVEdirector
5,000
0.0362%
$9.19$45,950+58.95%
2020-10-15PurchaseGORLIN STEVEdirector
15,100
0.1065%
$10.10$152,517+40.72%
2020-10-09PurchaseGORLIN STEVEdirector
282
0.002%
$9.61$2,710+50.83%
2020-10-07PurchaseGORLIN STEVEdirector
4,718
0.0343%
$9.42$44,444+55.36%
2020-09-22PurchaseGORLIN STEVEdirector
15,000
0.263%
$10.00$150,000+51.62%
Total: 17

Insider Historical Profitability

23.32%
DO CUONG VPresident & CEO
435854
2.3621%
$488,156.4820<0.0001%
GORLIN STEVEdirector
46358
0.2512%
$51,920.9672+59.63%
KIM JOANNE WENDYCFO
2000
0.0108%
$2,240.0010<0.0001%

Historical Insider Profitability vs. Competitors

$6,204,522
45
1.91%
$20.33M
$550,024
37
-2.68%
$21.05M
$1,363,112
33
15.03%
$21.87M
$206,127
21
-29.00%
$17.48M
$555,628
21
43.52%
$18.94M

BIVI Institutional Investors: Active Positions

Increased Positions29+93.55%611,318+273.74%
Decreased Positions11-35.48%78,432-35.12%
New Positions20New405,337New
Sold Out Positions6Sold Out75,056Sold Out
Total Postitions49+58.06%756,209+238.62%

BIVI Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Geode Capital Management, Llc$133.000.69%123,408+85,234+223.28%2024-12-31
Millennium Management Llc$132.000.68%122,619+122,619New2024-12-31
Vanguard Group Inc$98.000.5%90,282+33,445+58.84%2024-12-31
Drive Wealth Management, Llc$65.000.33%60,000+60,000New2024-12-31
Bank Of Montreal /Can/$54.000.28%50,000+50,000New2024-12-31
Ubs Group Ag$52.000.27%48,327+48,282+107,293.33%2024-12-31
Sanders Morris Harris Llc$43.000.22%40,000+40,000New2024-12-31
Prosperity Wealth Management, Inc.$34.000.18%31,650+31,650New2024-12-31
Two Sigma Investments, Lp$31.000.16%28,713+28,713New2024-12-31
Morgan Stanley$27.000.14%25,126+22,365+810.03%2024-12-31

Financial Ratios

Summary
Comparison with Competitors

Analyst Recommendations

Analyst Price Targets

No data is available at this moment.
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.